logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Grammar schools – closing the gap?

8 May 2014

Reports are suggesting that over half of the 164 selective schools in England are looking to amend their admission policies to give greater priority to disadvantaged children, i.e. those on free school meals. Over 30 grammar schools have already gained consent from the Department for Education to give priority on this basis with another 50 looking to do so. The move follows a report from the Sutton Trust which highlighted the low proportion of pupils on free school meals in grammar schools compared to the national average.

This move is clearly in accordance with wider government policies around increasing equality and choice in education and ensuring all children get access to quality educational provision. However, to make a greater difference you also need to ensure children get the firm foundations of learning in place at primary school to ensure they can realise their potential at secondary schools – whether those schools are comprehensive or selective.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up